Baird Financial Group’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.93M | Sell |
21,372
-702
| -3% | -$64.4K | ﹤0.01% | 1053 |
|
|
2025
Q4 | $1.98M | Buy |
22,074
+1,035
| +5% | +$98.1K | ﹤0.01% | 1042 |
|
|
2025
Q3 | $2.07M | Sell |
21,039
-18,086
| -46% | -$1.79M | ﹤0.01% | 1037 |
|
|
2025
Q2 | $3.57M | Sell |
39,125
-12,857
| -25% | -$1.24M | 0.01% | 827 |
|
|
2025
Q1 | $5.88M | Buy |
51,982
+5,957
| +13% | +$637K | 0.01% | 634 |
|
|
2024
Q4 | $4.86M | Sell |
46,025
-3,026
| -6% | -$325K | 0.01% | 685 |
|
|
2024
Q3 | $5.3M | Sell |
49,051
-6,401
| -12% | -$699K | 0.01% | 663 |
|
|
2024
Q2 | $6.02M | Sell |
55,452
-1,476
| -3% | -$174K | 0.01% | 616 |
|
|
2024
Q1 | $7.51M | Sell |
56,928
-6,641
| -10% | -$830K | 0.02% | 554 |
|
|
2023
Q4 | $7.74M | Buy |
63,569
+1,356
| +2% | +$151K | 0.02% | 533 |
|
|
2023
Q3 | $6.98M | Buy |
62,213
+18,653
| +43% | +$2.37M | 0.02% | 523 |
|
|
2023
Q2 | $6.34M | Sell |
43,560
-3,049
| -7% | -$414K | 0.02% | 555 |
|
|
2023
Q1 | $6.02M | Sell |
46,609
-53,533
| -53% | -$6.72M | 0.01% | 535 |
|
|
2022
Q4 | $12.8M | Sell |
100,142
-2,649
| -3% | -$307K | 0.03% | 378 |
|
|
2022
Q3 | $10.7M | Buy |
102,791
+4,369
| +4% | +$479K | 0.03% | 409 |
|
|
2022
Q2 | $10.3M | Sell |
98,422
-16,087
| -14% | -$1.91M | 0.03% | 430 |
|
|
2022
Q1 | $14.6M | Buy |
114,509
+12,956
| +13% | +$1.56M | 0.04% | 372 |
|
|
2021
Q4 | $12.5M | Buy |
101,553
+4,396
| +5% | +$575K | 0.03% | 393 |
|
|
2021
Q3 | $13.8M | Buy |
97,157
+11,917
| +14% | +$1.75M | 0.04% | 368 |
|
|
2021
Q2 | $13.3M | Buy |
85,240
+15,534
| +22% | +$2.52M | 0.03% | 368 |
|
|
2021
Q1 | $10.8M | Buy |
69,706
+1,302
| +2% | +$202K | 0.03% | 387 |
|
|
2020
Q4 | $10.2M | Sell |
68,404
-9,375
| -12% | -$1.32M | 0.03% | 383 |
|
|
2020
Q3 | $10.3M | Sell |
77,779
-983
| -1% | -$128K | 0.04% | 360 |
|
|
2020
Q2 | $9.13M | Buy |
78,762
+35,976
| +84% | +$4.15M | 0.03% | 361 |
|
|
2020
Q1 | $4.2M | Buy |
42,786
+13,731
| +47% | +$1.8M | 0.02% | 483 |
|
|
2019
Q4 | $4.22M | Buy |
29,055
+74
| +0.3% | +$10.2K | 0.02% | 570 |
|
|
2019
Q3 | $3.86M | Buy |
28,981
+2,027
| +8% | +$262K | 0.02% | 585 |
|
|
2019
Q2 | $3.08M | Buy |
26,954
+7,743
| +40% | +$907K | 0.01% | 655 |
|
|
2019
Q1 | $2.38M | Buy |
19,211
+1,805
| +10% | +$205K | 0.01% | 611 |
|
|
2018
Q4 | $1.75M | Buy |
17,406
+657
| +4% | +$73.9K | 0.01% | 669 |
|
|
2018
Q3 | $2.12M | Sell |
16,749
-11,290
| -40% | -$1.34M | 0.01% | 651 |
|
|
2018
Q2 | $3.03M | Buy |
28,039
+240
| +0.9% | +$26.1K | 0.02% | 547 |
|
|
2018
Q1 | $2.94M | Sell |
27,799
-744
| -3% | -$86.4K | 0.02% | 541 |
|
|
2017
Q4 | $3.34M | Buy |
28,543
+10,234
| +56% | +$1.16M | 0.02% | 499 |
|
|
2017
Q3 | $2.08M | Buy |
18,309
+3,570
| +24% | +$412K | 0.02% | 612 |
|
|
2017
Q2 | $1.84M | Buy |
14,739
+910
| +7% | +$108K | 0.01% | 630 |
|
|
2017
Q1 | $1.64M | Sell |
13,829
-11,574
| -46% | -$1.31M | 0.01% | 641 |
|
|
2016
Q4 | $2.54M | Sell |
25,403
-17,042
| -40% | -$1.83M | 0.02% | 522 |
|
|
2016
Q3 | $5.36M | Buy |
42,445
+284
| +0.7% | +$35.1K | 0.05% | 353 |
|
|
2016
Q2 | $5M | Buy |
42,161
+15,171
| +56% | +$1.72M | 0.05% | 357 |
|
|
2016
Q1 | $2.79M | Buy |
26,990
+14,017
| +108% | +$1.36M | 0.03% | 467 |
|
|
2015
Q4 | $1.29M | Buy |
12,973
+548
| +4% | +$53.6K | 0.01% | 628 |
|
|
2015
Q3 | $1.13M | Sell |
12,425
-961
| -7% | -$96.3K | 0.01% | 666 |
|
|
2015
Q2 | $1.42M | Buy |
+13,386
| New | +$1.48M | 0.01% | 636 |
|
Other funds holding ZBH
VCM
VPM
Baird Financial Group's ZBH Position: Q1 2026 in Review
Baird Financial Group reduced its Zimmer Biomet (ZBH) stake by 3.2% in Q1 2026, selling an estimated $64.4K and leaving 21,372 shares worth $1.93M. The position accounts for ﹤0.01% of the portfolio, ranked #1053.
Baird Financial Group first reported a position in ZBH in Q2 2015 and has held it in 44 quarters since. The position peaked at $14.6M in Q1 2022. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Baird Financial Group held 21,372 shares of Zimmer Biomet worth $1.93M as of Q1 2026.
- Baird Financial Group sold 702 Zimmer Biomet shares in Q1 2026, an estimated $64.4K.
- Zimmer Biomet made up ﹤0.01% of Baird Financial Group's portfolio in Q1 2026, its #1053 holding.
- Baird Financial Group first reported a position in Zimmer Biomet in Q2 2015 and has held it in 44 quarters since.
- Baird Financial Group's Zimmer Biomet position peaked at $14.6M in Q1 2022.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.